Interindividual variation in olanzapine concentration influenced by UGT1A4 L48V polymorphism in serum and upstream FMO polymorphisms in cerebrospinal fluid

J Clin Psychopharmacol. 2012 Apr;32(2):287-9. doi: 10.1097/JCP.0b013e31824997a8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antipsychotic Agents / blood*
  • Benzodiazepines / blood*
  • Benzodiazepines / cerebrospinal fluid*
  • Cytochrome P-450 CYP1A2 / metabolism*
  • Cytochrome P-450 CYP2D6 / metabolism*
  • Female
  • Humans
  • Male
  • Pirenzepine / analogs & derivatives*
  • Pirenzepine / blood*
  • Psychotic Disorders / blood*
  • Psychotic Disorders / cerebrospinal fluid*
  • Schizophrenia / blood*
  • Schizophrenia / cerebrospinal fluid*
  • Schizophrenia / drug therapy*
  • Smoking*
  • Weight Gain / physiology*

Substances

  • Antipsychotic Agents
  • Benzodiazepines
  • Pirenzepine
  • Cytochrome P-450 CYP1A2
  • Cytochrome P-450 CYP2D6